Deutsche Bank AG Raises Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Deutsche Bank AG boosted its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 51.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 172,127 shares of the company's stock after buying an additional 58,282 shares during the quarter. Deutsche Bank AG owned 0.07% of Oscar Health worth $2,313,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the business. JPMorgan Chase & Co. boosted its stake in shares of Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock worth $139,246,000 after buying an additional 8,051,379 shares during the last quarter. BIT Capital GmbH lifted its holdings in Oscar Health by 5,711.6% in the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock valued at $60,129,000 after acquiring an additional 4,396,872 shares during the period. Deerfield Management Company L.P. Series C boosted its position in Oscar Health by 50.7% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock worth $159,062,000 after purchasing an additional 3,983,325 shares in the last quarter. Gilder Gagnon Howe & Co. LLC grew its stake in shares of Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock worth $85,154,000 after purchasing an additional 2,151,256 shares during the period. Finally, Clearbridge Investments LLC purchased a new position in shares of Oscar Health during the 4th quarter valued at approximately $19,088,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Oscar Health

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the transaction, the director now owns 64,512 shares of the company's stock, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 24.39% of the company's stock.

Analysts Set New Price Targets

OSCR has been the topic of several analyst reports. Wall Street Zen lowered shares of Oscar Health from a "buy" rating to a "hold" rating in a research report on Thursday, May 22nd. Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their target price for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $20.08.

Oscar Health Price Performance

OSCR traded up $0.87 during midday trading on Tuesday, hitting $15.04. 4,995,063 shares of the company traded hands, compared to its average volume of 4,314,617. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The business has a 50 day simple moving average of $13.68 and a two-hundred day simple moving average of $14.59. The company has a market capitalization of $3.77 billion, a price-to-earnings ratio of -750.87 and a beta of 1.75.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.83 by $0.09. The company had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Oscar Health's quarterly revenue was up 42.2% on a year-over-year basis. During the same period in the previous year, the business earned $0.62 EPS. On average, equities analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.